UNICANCER: Prostatic Neoplasms trials

The registry lists 18 Prostatic Neoplasms studies with UNICANCER as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 13No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of RelapseRecruitingNCT06625970Phase 3
• Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)RecruitingNCT06496581Phase 3
• Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional ImagingRecruitingNCT06276465Phase 3
• Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After ProstatectomyActive, not recruitingNCT04181203Phase 3
• Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor RecurrenceActive, not recruitingNCT03438552Not applicable
• Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesActive, not recruitingNCT03143322Not applicable
• Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells KineticCompletedNCT03101046Phase 2
• A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerActive, not recruitingNCT01957436Phase 3
• Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsCompletedNCT01254513Phase 2
• Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)Active, not recruitingNCT00967863Not applicable
• Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate CancerCompletedNCT00667069Phase 3
• Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerCompletedNCT00423475Phase 3
• Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00104741Phase 3
• Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerCompletedNCT00104715Phase 3
• Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompletedNCT00055731Phase 3
• Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate CancerCompletedNCT00010244Phase 3
• Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate CancerTerminatedNCT00003682Phase 3
• Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerCompletedNCT00003607Phase 3